Research Paper Volume 15, Issue 18 pp 9479—9498
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer
Figure 4. Exploratory analysis of the CCCP risk score in ccRCC and melanoma cohort. (A, B) Kaplan-Meier curves of OS comparing patients with high- and low-risk in the ccRCC cohort (A) and melanoma cohort (B) treated with ICIs. (C) Comparison of immune cell infiltrations between patients with high- and low- risk score in melanoma cohort. (D) Comparison of immune cell infiltrations between patients with high- and low- risk score in ccRCC cohort. CCCP, complement and coagulation cascades pathway; ccRCC, clear cell renal cell carcinoma; Tfh, T follicular helper cells.